Series A biotech investors active in 2026.

An investor appears on this page only with a named, dated participation in a financing announced in the last 180 days, backed by a public source linked on the row. Dates shown are when each deal was announced, as established by research; where the linked post was published later, its date is shown beneath as "evidence posted". A separately confirmed closing date appears on the fund sheet where research established one. Rows whose latest evidence ages past 180 days are removed at the weekly rebuild, and rows with insufficient evidence are withheld rather than padded.